2005 Press Releases
Alimentary Health Ltd announces Gastrointestinal Licensing Agreement with Procter & Gamble
Alimentary Health Ltd (AH), a biotechnology company based in Cork, has
announced (12 December 2005) the signing of a worldwide licensing
agreement with The Procter & Gamble Company (NYSE:PG) for
Gastrointestinal (GI) indications.
AH was established in 1999 and is a leader in pioneering the
development of safe and effective therapeutics for GI and other
indications. "This deal is the culmination of a close working
partnership with P&G over a number of years and will transition us
into a revenue generating company" said Barry Kiely, CEO of AH, "we are
proud to be associated with such a leading multi-national company".
"P&G is excited about the opportunity to formalise our work with
Alimentary Health and continue our collaboration with such a leading
edge company," said Rowena Pullan, Director, Global Personal Health
Care Research and Development.
GI disorders are common and the treatment of GI diseases constitutes
one of the largest pharmaceutical markets in the world with an annual
market in excess of $20 billion.
About Alimentary Health
Alimentary Health is a development stage specialty biotechnology
company linked to the Alimentary Pharmabiotic Centre (APC) based at
University College Cork. Alimentary Health is focused on the discovery,
development and commercialization of proprietary treatments for
gastrointestinal disorders and other inflammatory conditions.
About P&G (NYSE:PG)
Three billion times a day, P&G brands touch the lives of people
around the world. The company has one of the strongest portfolios of
trusted, quality, leadership brands, including Pampers(r), Tide(r),
Ariel(r), Always(r), Whisper(r), Pantene(r), Mach3(r). Bounty(r),
Dawn(r), Pringles(r), Folgers(r), Charmin(r), Downy(r), Lenor(r),
Iams(r), Crest(r), Oral-B(r), Actonel(r), Duracell(r), Olay(r), Head
& Shoulders(r), Wella, Gillette(r), and Braun. The P&G
community consists of almost 140,000 employees working in over 80
countries worldwide. Please visit www.pg.com for the latest news and
in-depth information about P&G and its brands.
About APC
The Alimentary Pharmabiotic Centre (APC) is a Science Foundation
Ireland (SFI) funded research centre headquartered in University
College Cork (UCC), with scientists and clinicians also based in
Teagasc Moorepark, Cork University Hospital and Alimentary Health Ltd.
The APC is investigating mechanisms by which intestinal bacteria
influence health and disease and is developing new therapies for
lifelong debilitating gastrointestinal diseases such as
gastroenteritis, ulcerative colitis and Crohn's disease. For
information please visit http://apc.ucc.ie/
161MMcS
« Back to 2005 Press Releases